Eagle LogoPEPTIDE INITIATIVE

Peptide Database

Adipotide
Weight Management
AOD-9604
Weight Management
BPC-157
Healing & Recovery
Cagrilintide
Weight Management
CJC-1295
Growth Hormone
DSIP
Sleep & Recovery
Epithalon
Anti-Aging
GHK-Cu
Anti-Aging
GHRP-2
Growth Hormone
HCG
Hormone Support
Hexarelin
Growth Hormone
HGH
Growth Hormone
IGF-1 LR3
Growth Hormone
Kisspeptin
Hormone Support
Melanotan-2
Cosmetic
MOTS-C
Metabolic
NAD+
Anti-Aging
Oxytocin Acetate
Hormone Support
PEG-MGF
Recovery
PT-141
Sexual Health
Retatrutide
Weight Management
Selank
Cognitive
Semaglutide
Weight Management
Semax
Cognitive
Sermorelin
Growth Hormone
Snap-8
Cosmetic
SS-31
Mitochondrial
TB-500
Healing & Recovery
Tesamorelin
Growth Hormone
Thymosin Alpha-1
Immune
Tirzepatide
Weight Management
Total Peptides: 31
Back to Home
PEG-MGF
EfficacyHigh
Studies8
Participants673
StatusAvailable

PEG-MGF

Pegylated Mechano Growth Factor

PEG-MGF is a pegylated variant of Mechano Growth Factor, an engineered form of IGF-1 designed for enhanced stability and prolonged action. The pegylation process extends the half-life from minutes to days, making it highly effective for muscle fiber hyperplasia, satellite cell activation, and accelerated muscle tissue repair. Unlike standard IGF-1, PEG-MGF specifically targets muscle-specific growth pathways with reduced systemic effects.

Complete Dosing Guide

Quick Reference

100-400
Typical Dose
Daily
Frequency
24-72
Half-Life
SubQ
Route

Administration Method

Subcutaneous injection once daily

Step-by-Step Dosing Protocol

Initial
100-400 mcg daily (post-workout or pre-sleep)
Getting started
Follow gradual escalation approach
Maintenance
Optimized dose
Sustained benefits
Continue at effective dose
Cycling
Break period
Recovery
Take breaks to maintain effectiveness

Dosing Guidelines

Research Protocol

Initial dosing begins at 100 mcg daily for 1-2 weeks to assess tolerance. Most research protocols use 200-300 mcg daily as the therapeutic dose, with advanced users utilizing up to 400 mcg daily. Timing is crucial - post-workout administration (within 30 minutes) maximizes muscle activation, while pre-sleep dosing takes advantage of natural growth hormone release. Cycles typically run 8-16 weeks with 4-week breaks.

Simple Explanation

Most people start with 100 mcg per day for the first couple weeks to see how they respond. The sweet spot seems to be 200-300 mcg daily for most people. The best times to inject are right after your workout or before bed. Most research cycles last 2-4 months with a month break in between cycles.

Mixing & Injection

Technical Instructions

Subcutaneous injection using insulin syringes (29-31 gauge, 0.5-1 inch) into areas with sufficient subcutaneous fat. Common sites include abdominal area (2 inches from navel), anterior thigh, or deltoid region. Rotate injection sites to prevent tissue damage or lipodystrophy. Reconstitution requires bacteriostatic water, typically 1-2ml per vial. Store reconstituted solution refrigerated and use within 14 days.

Step-by-Step Guide

Subcutaneous injection using insulin syringes (29-31 gauge, 0.5-1 inch) into areas with sufficient subcutaneous fat. Common sites include abdominal area (2 inches from navel), anterior thigh, or deltoid region. Rotate injection sites to prevent tissue damage or lipodystrophy. Reconstitution requires bacteriostatic water, typically 1-2ml per vial. Store reconstituted solution refrigerated and use within 14 days.

Clinical Administration Guidelines

Injection Protocol

  • Subcutaneous injection per protocol
  • Rotate injection sites
  • Consistent daily timing
  • Follow protocol guidelines

Monitoring Schedule

  • Regular progress monitoring
  • Health parameter monitoring
  • Laboratory monitoring
  • Safety monitoring

Dosage Calculator

Loading Calculator...

Medical Disclaimer

PEG-MGF is a research chemical not approved by the FDA for human use. This information is for educational purposes only and should not replace consultation with healthcare providers. Individual results may vary significantly. Research use only - not intended for human consumption or therapeutic application.